JOHN C. HODGMAN
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
Sarepta Therapeutics, Inc.
Filing Date
Source Excerpt
2010-05-04
John C. Hodgman 52,500 Fees Earned or Paid in Cash, 5,500 Stock Awards, 18,592 Option Awards, Total 76,592
Data sourced from SEC filings. Last updated: 2025-12-07